Back to Search
Start Over
Additional file 3: of Factors associated with the achievement of biological disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: the ANSWER cohort study
- Publication Year :
- 2018
- Publisher :
- figshare, 2018.
-
Abstract
- Table S1. Types of bDMARDs and hazard ratios for bDMARD-free remission failure in bDMARD-naïve patients (univariate analysis). bDMARD-naïve patients classified into four groups based on types of bDMARDs. Hazard ratios with 95% CIs obtained using Cox’s proportional hazard model. CI confidence interval, bDMARD biological disease-modifying antirheumatic drug, TNFi(mAb) monoclonal antibodies against TNF (infliximab, adalimumab, and golimumab), TNFi(R/P) soluble TNF receptor or Fab fragments against TNF fused with polyethylene glycol (etanercept and certolizumab), CTLA4-Ig abatacept, IL-6Ri interleukin-6 receptor inhibitor (tocilizumab) (DOCX 15 kb) (DOCX 15 kb)
- Subjects :
- musculoskeletal diseases
Subjects
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....6df693ba82c23ca52186a10ca0279f80
- Full Text :
- https://doi.org/10.6084/m9.figshare.6933437.v1